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Stratification Analysis of an Osteoarthritis Genome
Screen—Suggestive Linkage to Chromosomes 4, 6,
and 16
To the Editor:
We have previously carried out a two-stage genomewide
linkage screen for osteoarthritis (MIM 165720) suscep-
tibility loci, using an affected-sibling-pair approach
(Chapman et al. 1999). In stage 1 of this screen, we
tested 272 microsatellite markers in 297 families, each
of which contained at least one pair of siblings who had
undergone hip-, knee-, or hip and knee–replacement sur-
gery for primary osteoarthritis. Loci that demonstrated
evidence for linkage at nominal were then takenP = .05
through to stage 2, in which they were tested against a
further 184 families. Sixteen markers within nine ge-
nomic regions from stage 1 had evidence of linkage, at
. When the data for stages 1 and 2 were com-P = .05
bined, the P value decreased for 3 of the 16 loci (D2S202,
D11S907, and D11S903) and was constant for a 4th
(D11S901). We subsequently concentrated our analysis
on the chromosome regions to which these markers map.
To test these linkages further, we genotyped additional
markers and obtained maximum multipoint LOD scores
(MLSs) of 1.2 for chromosome 2 and 3.1 for chromo-
some 11.
Because there is evidence, from epidemiological, twin,
and segregation studies, that the genetic contribution to
osteoarthritis differs between the sexes and between dif-
ferent joint groups (Lindberg 1986; Cooper et al. 1994;
Kaprio et al. 1996; Chitnavis et al. 1997; Felson et al.
1998), we stratified our chromosomes 2 and 11 linkage
data according to sex and site of osteoarthritis (hip or
knee). This stratification indicated that the suggestion of
linkage to chromosome 2 was principally accounted for
by affected sibling pairs with hip osteoarthritis (MLS
2.2), whereas the suggestion of linkage to chromosome
11 was restricted to affected female pairs (MLS 2.8).
Because this analysis highlighted substantial differences
between the strata tested, we have now reanalyzed stage
1 of our genome screen, for the remaining 20 autosomes,
to determine whether any regions harbor susceptibility
loci that are obscured in the unstratified data set. We
stratified our stage 1 data into the same six strata tested
in our analysis of chromosomes 2 and 11: affected fe-
males only (132 families), affected males only (60 fam-
ilies), hips only (194 families), knees only (34 families),
female hip (85 families), and male hip (44 families). (A
more detailed breakdown of these families can be found
in the study by Chapman et al. [1999].) We did not
stratify for female knee or male knee, because the num-
ber of families was too small (16 and 4, respectively) to
allow reliable inference of linkage. Multipoint linkage
analysis was performed on the stratified data by means
of the ASPEX program.
Ten of the 20 autosomes have one or more multipoint
peaks with uncorrected for one or more ofMLS  1.0
the six strata tested (table 1). The highest MLS is 3.9,
for chromosome 4q in the female-hip strata, followed
by 2.9, for chromosome 6 in the hip-only strata, and
2.1, for chromosome 16 in the female-hip strata. When
we adjust MLS values to correct for the seven models
tested (one unstratified analysis and six stratified anal-
yses), by deducting from the original valueslog = 0.87
(Kidd and Ott 1984), chromosome 4 has an MLS value
of 3.1, chromosome 6 has an MLS value of 2.1, and
chromosome 16 has an MLS value of 1.3. The uncor-
rected multipoint plots of these three chromosomes are
shown in figure 1.
The suggestion of linkage on chromosome 4 is cen-
tered on 4q12–4q21.2 and is restricted to female pairs
with hip disease. Roby et al. (1999) have recently re-
ported linkage of chromosome 4q to severe early-onset
hip osteoarthritis in a large pedigree of Dutch origin.
This locus maps to the telomeric end of 4q (4q35), plac-
ing it 150 cM distal to the linkage that we have observed.
It is therefore unlikely that the two linkages have de-
tected the same locus.
More than 50 cM of chromosome 6 has an uncor-
rected in the hip-only stratum, betweenMLS  2.0
markers D6S257 and D6S262. This region of chromo-
some 6 contains a strong candidate gene for osteoar-
thritis, COL9A1 (6q12–6q13). This gene maps within
the 11-cM interval between D6S257 and D6S286 and
encodes the a1 chain of type IX collagen. This collagen
is a quantitatively minor cartilage collagen that deco-
rates the type II collagen fibril and that interacts with
extrafibrillar macromolecules (Ayad et al. 1994). Two
transgenic mouse models have demonstrated that mu-
tations in the equivalent mouse gene can result in an
osteoarthritis phenotype. In the first model, a truncated
form of the gene resulted in mice with a mild osteo-
chondrodysplasia phenotype and secondary osteoar-
thritis (Nakata et al. 1993). In the second model, a
knockout mouse had no congenital abnormality but de-
veloped a severe osteoarthritis that was comparable, in
timing and pathology, to human primary osteoarthritis
(Fa¨ssler et al. 1994). A more detailed analysis of this
second model revealed that the synthesis of the a1 poly-
peptide chain was necessary for type IX collagen assem-
bly (Hagg et al. 1997).
Chromosome 16 does not contain any known genes
that can be considered as strong candidates for osteo-
arthritis susceptibility. As more genes are mapped, can-
didate loci on this chromosome may become apparent.
Overall, the stratification of our genome screen has
revealed additional chromosomal regions that may har-
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Figure 1 Multipoint analysis. A, Chromosome 4, female hip
( families) and female only ( families). B, Chromosomen = 85 n = 132
6, hip only ( families). C, Chromosome 16, female hip (n = 194 n =
families) and female only ( families).85 n = 132
Table 1
Stratified MLSs
Chromosome MLS (Corrected)a Cytogenetic Position Flanking Markers Stratum
1 1.3 (!1.0) 1q31–1q44 D1S238, D1S103 Female only
3 1.5 (!1.0) 3p25–3p21 D3S1263, D3S1289 Female hip
3 1.5 (!1.0) 3p25–3p21 D3S1263, D3S1289 Female only
3 1.0 (!1.0) 3p21–3p14 D3S1289, D3S1285 Hip only
4 3.9 (3.1) 4q12–4q21.2 D4S398, D4S250 Female hip
4 1.7 (!1.0) 4q12–4q21.2 D4S398, D4S250 Female only
5 1.3 (!1.0) 5p13.3–5q11.1 D5S419, D5S407 Female only
6 2.9 (2.1) 6p21.1–6q22.1 D6S1610, D6S314 Hip only
6 1.8 (1.0) 6p23–6p21.3 D6S422, D6S265 Female hip
6 1.3 (!1.0) 6p21.3–6q15 D6S291, D6S286 Female hip
6 1.2 (!1.0) 6q13–6q22.1 D6S462, D6S314 Male hip
6 1.1 (!1.0) 6p23–6p21.3 D6S422, D6S265 Female only
7 1.5 (!1.0) 7q11.23–7q21.2 D7S502, D7S524 Hip only
7 1.3 (!1.0) 7q22.1–7q32 D7S2502, D7S684 Hip only
8 !1.0 (—) — — —
9 !1.0 (—) — — —
10 !1.0 (—) — — —
12 1.3 (!1.0) 12p12.1–12q11 D12S358, D12S87 Female only
12 1.4 (!1.0) 12q13.3–12q23 D12S43, D12S338 Female hip
12 1.3 (!1.0) 12q13.3–12q23 D12S43, D12S338 Female only
13 !1.0 (—) — — —
14 1.2 (!1.0) 14q24.3–14q32.2 D14S74, D14S51 Male hip
14 1.1 (!1.0) 14q24.3–14q32.2 D14S74, D14S51 Male only
15 !1.0 (—) — — —
16 2.1 (1.3) 16p13.1–16q12.1 D16S407, D16S261 Female hip
16 1.7 (!1.0) 16p13.1–16q12.1 D16S407, D16S261 Female only
16 1.1 (!1.0) 16p13.1–16q12.1 D16S407, D16S261 Hip only
16 2.0 (1.2) 16q21–16q23 D16S265, D16S289 Female only
17 !1.0 (—) — — —
18 1.1 (!1.0) 18p11.32–18p11.1 D18S63, D18S53 Female hip
19 !1.0 (—) — — —
20 !1.0 (—) — — —
21 !1.0 (—) — — —
22 !1.0 (—) — — —
a deducted from the original MLS values.log = 0.87
bor susceptibility loci for osteoarthritis. Stratification in-
creases the level of genetic homogeneity and can there-
fore assist in the mapping of loci for complex traits. Our
analysis highlights the potential utility of this approach
for osteoarthritis.
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